Tipsheet
What matters at India’s listed companies
Brief /Earnings / Financial Services

Almondz Global Securities revenue climbs 34%, but profit slips

The company eyes June for biofuel procurement contracts in Odisha as infrastructure advisory growth targets reach 18-20%.


Mkt cap₹245 cr
P/E8.84×
ROE7.18%
Debt / eq.0.19
₹5.37 cr Consolidated net profit for Q4, down from ₹6.04 cr a year ago.

What's new with Almondz Global Securities Ltd.

  • March quarter revenue rose 34% year-on-year to ₹72.55 crore.
  • The delayed Odisha biofuel plant is finally complete.
  • Oil marketers plan to award procurement contracts in June.

Why this matters for Almondz Global Securities Ltd.

Revenue growth is clear, but margin compression took a bite out of the bottom line. The story now shifts from completion to commercialization of the Odisha plant.

What we're watching

  • Whether oil marketing companies confirm the expected June contract timeline.
  • Conversion of the ₹260 crore advisory order book into recognized revenue.
  • The trajectory of net margins after the recent slip.

The full read

Almondz Global Securities logged a 34% revenue jump to ₹72.55 crore in the March quarter, but profit didn't follow the trend. Net profit dropped to ₹5.37 crore compared to ₹6.04 crore in the same period last year. Management pointed to two pillars for the coming fiscal year: a completed biofuel plant in Odisha and a ₹260 crore order book in infrastructure advisory. The biofuel facility remains the primary point of uncertainty. While construction is finished, the company awaits procurement contracts from oil marketers, which are now slated for June. If those contracts land, they provide the revenue base for the advisory segment's projected 18-20% growth. For now, Almondz is caught in a familiar transition—trading current profitability for the promise of pending industrial tenders. June is the next real test.

Mentioned: Almondz Global Securities · Odisha biofuel plant · ₹260 cr advisory order book
Primary source BSE · NSE · Tijori

Our reading of the company's own disclosure. Always confirm against the original source.